أعرض في EDS

Author response for 'Efficacy and safety of lobeglitazone versus sitagliptin as an add‐on to metformin in type 2 diabetes with metabolic syndrome over 24 weeks'

التفاصيل البيبلوغرافية
العنوان:	Author response for 'Efficacy and safety of lobeglitazone versus sitagliptin as an add‐on to metformin in type 2 diabetes with metabolic syndrome over 24 weeks'
المؤلفون:	Hyoung Woo Lee, Sung Wan Chun, Ji A Seo, Kyoung Jin Kim, Kun Ho Yoon, Bong Soo Cha, Kyong Soo Park, Mi-Kyung Kim, Kyung Mook Choi, Soo Lim, Ho Sang Shon, Ji‐Oh Mok, Dong Seop Choi, Doo Man Kim, Sin Gon Kim
بيانات النشر:	Wiley, 2020.
سنة النشر:	2020
مصطلحات موضوعية:	medicine.medical_specialty, business.industry, Internal medicine, Sitagliptin, medicine, Lobeglitazone, Type 2 diabetes, Metabolic syndrome, medicine.disease, business, medicine.drug, Metformin
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ac065977ceb6c9f50aa4e3457332c32 https://doi.org/10.1111/dom.14085/v2/response1
رقم الأكسشن:	edsair.doi.dedup.....3ac065977ceb6c9f50aa4e3457332c32
قاعدة البيانات:	OpenAIRE

الوصف
الوصف غير متاح.